CSF3 and acute myeloid leukemia: Decitabine is a demethylation agent that is effective and safe in older patients with AML; its combination with other regimens (e.g., CAG (Ara-C, Aclarubicin, and G-CSF), retinoic acid) results in a higher OS rate than decitabine alone (Bian et al., 2019).